Results

Total Results: 10 records

Showing results for "episode".

1. Clostridium Difficile (C.Diff) Infection Treatment Pathway Updated March 2019 (pdf file)
   cds.ahrq.gov/sites/default/files/cds/artifact/686/Clostridium%20difficile%20(C.diff)%20Infection%20Treatment%20Pathway_updated%20March%202019.pdf
   June 20, 2019 - NO significant abdominal findings Management of fulminant CDI NO, First CDI Episode YES, Recurrent … CDI Episode Consult infectious disease (ID) for consideration of fecal microbiota transplantation … YES, Recurrent CDI Episode NO, First CDI Episode Complete 14 day course without subsequent taper if

2. Pain Management Summary Clincial Decision Support Toolkit For Repository (xls file)
   cds.ahrq.gov/sites/default/files/cds/artifact/476/Pain%20Management%20Summary%20Clincial%20Decision%20Support%20Toolkit_for%20Repository.xlsx
   January 01, 2003 - 1091719 0.55 ML Sodium Hyaluronate 10 MG/ML Prefilled Syringe F32.0 Major depressive disorder, single episode … 1091723 0.4 ML Sodium Hyaluronate 10 MG/ML Prefilled Syringe F32.1 Major depressive disorder, single episode … Sulfates 40 MG/ML / Sodium Hyaluronate 30 MG/ML Prefilled Syringe F32.2 Major depressive disorder, single episode … 0.4 ML Sodium Hyaluronate 10 MG/ML Prefilled Syringe) } Pack F32.3 Major depressive disorder, single episode … 0.55 ML Sodium Hyaluronate 10 MG/ML Prefilled Syringe) } Pack F32.9 Major depressive disorder, single episode

3. Pain Management Summary Clincial Decision Support Toolkit For Repository 0 (xls file)
   cds.ahrq.gov/sites/default/files/cds/artifact/476/Pain%20Management%20Summary%20Clincial%20Decision%20Support%20Toolkit_for%20Repository_0.xlsx
   January 01, 2003 - 1091719 0.55 ML Sodium Hyaluronate 10 MG/ML Prefilled Syringe F32.0 Major depressive disorder, single episode … 1091723 0.4 ML Sodium Hyaluronate 10 MG/ML Prefilled Syringe F32.1 Major depressive disorder, single episode … Sulfates 40 MG/ML / Sodium Hyaluronate 30 MG/ML Prefilled Syringe F32.2 Major depressive disorder, single episode … 0.4 ML Sodium Hyaluronate 10 MG/ML Prefilled Syringe) } Pack F32.3 Major depressive disorder, single episode … 0.55 ML Sodium Hyaluronate 10 MG/ML Prefilled Syringe) } Pack F32.9 Major depressive disorder, single episode

4. Jun-2017-Cholesterol-Wg-Notes (doc file)
   cds.ahrq.gov/sites/default/files/workgroups/241/jun-2017-cholesterol-wg-notes.docx
   January 01, 2017 - Cholesterol Management Work Group Meeting Summary Date 06/21/2017 Time 1:30 – 2:45 PM EST AGENDA · Welcome and Review of Agenda · Gather Feedback on Additional Details Required to Support Development of the eCQM Artifact · Next Steps and Closing · SUMMARY Welcome CAMH welcomed the WG Members to the Jun…

5. CDS Connect Maintenance and Update Final Report Year 4 2020 (pdf file)
   cds.ahrq.gov/sites/default/files/AHRQ_Final_Report_2020.pdf
   January 01, 2020 - Decision Support, to promote the use of standards and pilot testing in CDS o Participated in a podcast episode … Listen, Learn, Informed Choice. episode included in the collection and worked with Mr. van Leeuwen to

6. Occupational Factors Which Impact Diabetes, A Final Knowledge Resource Report (2015) (pdf file)
   cds.ahrq.gov/sites/default/files/cds/artifact/171/Occupational%20Factors%20which%20Impact%20Diabetes,%20%20A%20Final%20Knowledge%20Resource%20Report%20(2015).pdf
   January 01, 2015 - Using Electronic Health Records and Clinical Decision Support to Provide Guidance on Occupational Factors which Impact Diabetes: A Final Knowledge Resource Report Revised and resubmitted December 4, 2015 The Diabetes subject matter expert (SME) group Convened by the Association of Occupational and Environmenta…

7. Alcohol Screening Using the USAUDIT (Alcohol Use Disorders Identification Test, Adapted for Use in the United States) (pdf file)
   cds.ahrq.gov/sites/default/files/cds/artifact/1161/USAUDIT_Alcohol_Screening_IG_v2.pdf
   June 16, 2020 - Alcohol Screening Using the USAUDIT (Alcohol Use Disorders Identification Test, Adapted for Use in the United States) Prepared for: Centers for Disease Control and Prevention CMS Alliance to Modernize Healthcare (Health FFRDC) A Federally Funded Research and Development Center Adapting Clinical Guidelines f…

8. Alcohol Screening Using the USAUDIT (Alcohol Use Disorders Identification Test, Adapted for Use in the United States) (pdf file)
   cds.ahrq.gov/sites/default/files/cds/artifact/1161/USAUDIT_Alcohol_Screening_IG%20V3.pdf
   June 16, 2020 - Alcohol Screening Using the USAUDIT (Alcohol Use Disorders Identification Test, Adapted for Use in the United States) Prepared for: Centers for Disease Control and Prevention CMS Alliance to Modernize Healthcare (Health FFRDC) A Federally Funded Research and Development Center Adapting Clinical Guidelines f…

9. Alcohol Screening Using the WHO AUDIT: Implementation Guide (pdf file)
   cds.ahrq.gov/sites/default/files/cds/artifact/1166/WHO_Alcohol_Screening_IG_v2.pdf
   June 22, 2020 - Alcohol Screening Using the WHO AUDIT: Implementation Guide Prepared for: Centers for Disease Control and Prevention CMS Alliance to Modernize Healthcare (Health FFRDC) A Federally Funded Research and Development Center Adapting Clinical Guidelines for the Digital Age: Alcohol Screening and Brief Intervent…

10. Alcohol Screening Using the WHO AUDIT: Implementation Guide (pdf file)
    cds.ahrq.gov/sites/default/files/cds/artifact/1166/WHO_Alcohol_Screening_IG%20V3.pdf
    June 22, 2020 - Alcohol Screening Using the WHO AUDIT: Implementation Guide Prepared for: Centers for Disease Control and Prevention CMS Alliance to Modernize Healthcare (Health FFRDC) A Federally Funded Research and Development Center Adapting Clinical Guidelines for the Digital Age: Alcohol Screening and Brief Intervent…